Bicisate
Active ingredient: Bicisate
In short: Tc99m bicisate is indicated as an adjunct to conventional CT or MRI imaging in the localization of stroke in patients in whom stroke has already been diagnosed
What is Bicisate used for?
Tc99m bicisate is indicated as an adjunct to conventional CT or MRI imaging in the localization of stroke in patients in whom stroke has already been diagnosed
Bicisate dosage
The recommended dose for a 70 kg patient is 10-30 mCi
Warnings & precautions
Do not take this medicine if: There are no known contraindications for this preparation.
About this medicine
AnazaoHealth supplies ECD as a compounded kit for preparing Tc99m ECD. Each Reaction vial contains 1.35 mg of ECD, 0.54 edetate disodium, 36mg mannitol and 0.125 mg stannous chloride dehydrate. The vial is back filled with inert gas and may contain a partial vacuum.
Each ECD buffer vial contains a total volume of 1 mL that includes 6.15 mg sodium phosphate dibasic and 0.69 mg sodium phosphate monobasic
How it works: Tc99m Bicisate forms a stable, lipophilic complex that crosses intact cell membranes and blood brain barrier by passive diffusion. The amount of tc99m bicisate is stable in the brain until about 6 hours
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID e094cb1d-80fe-4277-b8f4-9817918f8c76. Read the full official label on DailyMed.